Clinical Research
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2007; 13(2): 257-263
Published online Jan 14, 2007. doi: 10.3748/wjg.v13.i2.257
Figure 1
Figure 1 Quantitative values of cytokeratin-19 transcription in blood, bone marrow and peritoneal lavage of the patients with pancreatic cancer. 1Cut-off: Maximal expression of CK-19 mRNA in healthy control patients.
Figure 2
Figure 2 Quantitative analysis of CK-19 expression in blood (mean ± SD). aP < 0.05 vs pancreatic cancer.
Figure 3
Figure 3 Quantitative CK-19 expression in peritoneal lavage of the patients with pancreatic cancer (mean ± SD, aP < 0. 05 vs pancreatic cancer).
Figure 4
Figure 4 Quantitative CK-19 expression in peritoneal lavage of the patients with tumors (mean ± SD). aP < 0.05 vs pT1/2; cP < 0.05 vs pG1.